CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies The Prevalence of Myocardial Bridging Associated with Coronary Endothelial Dysfunction in Patients with Chest Pain and Non-Obstructive Coronary Artery Disease Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) When, where, and how to target vascular inflammation in the post-CANTOS era? Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Original Research2024 Apr;17(4):382-391.

JOURNAL:JACC Cardiovasc Imaging. Article Link

High-Risk Plaques on Coronary Computed Tomography Angiography: Correlation With Optical Coherence Tomography

D Kinoshita, K Suzuki, IK Jang et al. Keywords: CTA, OCT, HRP, MACE

PDF